May autophagy be a novel biomarker and antitumor target in colorectal cancer?

Area of Science:

• Cellular Biology
• Oncology
• Molecular Medicine

Background:

• Autophagy is a fundamental catabolic process crucial for maintaining cellular homeostasis through the degradation of damaged components.
• Impaired autophagy is increasingly recognized as a significant factor in the development and progression of various cancers, including colorectal cancer (CRC).
• Colorectal cancer (CRC) presents a major global health challenge due to its high incidence, poor survival rates, and resistance to current treatments.

Purpose of the Study:

• To review and synthesize current knowledge on the role of autophagy in colorectal cancer (CRC) development.
• To explore the potential of autophagy as a prognostic and predictive biomarker in CRC.
• To evaluate autophagy as a therapeutic target for novel antitumor strategies in CRC.

Main Methods:

• Comprehensive literature review of studies investigating autophagy in colorectal cancer.
• Analysis of research on autophagy's involvement in CRC carcinogenesis, metastasis, and response to therapy.
• Synthesis of findings to elucidate the multifaceted role of autophagy in CRC.

Main Results:

• Autophagy's role in CRC is complex and context-dependent, with studies yielding inconsistent results.
• Evidence suggests autophagy can act as both a tumor suppressor and a tumor promoter in CRC, depending on the stage and specific molecular context.
• Autophagy modulation impacts CRC cell behavior, including proliferation, survival, and resistance to chemotherapy.

Conclusions:

• Autophagy is a critical player in colorectal cancer, exhibiting dual roles throughout tumorigenesis.
• Further research is needed to clarify the precise mechanisms and context-specific functions of autophagy in CRC.
• Targeting autophagy presents a promising avenue for developing innovative diagnostic biomarkers and therapeutic interventions for colorectal cancer.